◆ 会议时间：2025年10月23-26日
◆ 会议地点：泰国 曼谷
◆ 会议简介：
2025年第37届国际乳头瘤病毒学会(IPVS)年会将于2025年10月23-26日在泰国曼谷举办，会议由国际乳头瘤病毒学会（IPVS）主办，大会将通过研讨会、邀请讲座、口头报告和海报会议等形式展示最新的研究结果，会议将包括基础科学、临床研究以及公共卫生、流行病学和实施科学三个主要主题。IPVC将汇集来自世界各地的研究人员、临床医生和其他相关卫生专业人士，一起分享在全球控制HPV疾病过程中的有关乳头瘤病毒及其相关疾病的知识和观点。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）.
国际乳头瘤病毒学会(IPVS)是乳头瘤病毒研究领域的国际权威组织。IPVS成立于2000年，是一个由研究动物和人类乳头瘤病毒及其相关疾病的生物医学科学家组成的非营利性国际组织，IPVS的使命是为消除乳头瘤病毒相关疾病做出贡献。
IPVC 2025 – The 37th Annual Conference of the International Papillomavirus Society
Date:
October 23-26, 2025
Venue:
Bangkok, Thailand
Organized by:
International Papillomavirus Society (IPVS)
摘要征文投稿：
Abstract Submission Opens:
Wednesday, March 19th, 2025
Abstract Submission Closes: Monday, May 12, 2025
Late-Breaking Submission Opens: June 30, 2025
Late-Breaking Submission Deadline: Monday, August 25th, 2025
GUIDELINES FOR ABSTRACT SUBMISSION
All abstracts must be submitted via this webpage. Please note that the Conference Secretariat is not able to accept abstracts submitted via e-mail, fax or post.
- All abstracts must be submitted in English.
- Each abstract should not exceed 300 words.
- The abstract title should not exceed 25 words.
- The following structure must be followed when submitting an abstract:
- Introduction
- Methods
- Results
- Conclusions
Presentation Type
Please choose one of the following presentation types:
- Poster
- Poster Discussion (Short Oral)
- Oral Presentation
The Scientific Committee will determine whether the abstract will be accepted for presentation, with consideration given to the author’s preference.
Authorship
The submitting author should also be the author for correspondence. An individual may be the submitting author on any number of abstracts.
The presenting author may or may not be the submitting/corresponding author. An individual may be the presenting author on a maximum of 3 abstracts.
Commercial Independence Guidelines
The IPVS makes every effort to ensure the scientific program is free of commercial bias. As such, before submitting an abstract, please read the guidelines here.
Notification for Peer Review Outcome
Notification of abstract acceptance or non-acceptance will be emailed to the person listed on the abstract as Presenting author.
Basic Information
- Full first and family name(s) of submitting/corresponding author and all co-authors.
- Affiliation details: department, institution/hospital, city, state (if relevant), country.
- Abstract title – The title is limited to 25 words in UPPER CASE (e.g. COMMON BLEEDING DISORDERS)
- Abstract text – The text is limited to 300 words.
- Abstract topic – Abstracts must be allocated to a specific topic for the Scientific Program. Please choose from the list of topics.
- Keywords – Please enter 1 to 3 keywords that define your abstract. The keywords must be in English and can include numbers.
- Conflict of interest disclosure – Abstract submitter will be required to disclose any conflict of interest in the submission form.
- Publication embargo – All abstracts will be published on the 1st day of the Conference (November 12, 2024)
SUBMISSION REQUIREMENTS
- Each abstract can contain up to three images (media files) and/or three tables. The maximum file size of each image or table is 700 KB.
- Please do not submit multiple copies of the same abstract.
- Original research and updated research are strongly recommended.
- The submitting/corresponding author is required to ensure that all co-authors are aware of the content of the abstract before submitting it to the Secretariat.
- All notifications regarding abstract status, including notifications regarding abstract submission, abstract acceptance and scheduling, will be sent to the presenting author. The presenting author will be responsible for informing the other co-authors about the status of the abstract. Please refer to your abstract by abstract ID sent to you in the confirmation email, in all correspondence regarding the abstract.
- The Committee will endeavor to schedule and allocate abstracts according to authors’ preferences but reserves the right to decide on the final form of presentation.
- One of the abstract authors must attend the Conference and present the abstract to ensure that the abstract is included in the Scientific Program.
- Only abstracts of presenting authors who have registered for the Conference and have paid the registration fee by the deadline will be scheduled for presentation.
- The identity of the presenting author can be changed until the deadline.
- All abstracts must be submitted and presented in clear English with accurate grammar and spelling.
- Upon submission, the submitting/corresponding author confirms that the abstract has been proofread and that all information is correct.
The submitting/corresponding author accepts that the content of the abstract cannot be modified or corrected after final submission and that it will be published exactly as submitted.
ABSTRACT SUBMITTERS’ DECLARATION
During abstract submission you will be asked to confirm that you agree to the following:
- I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published as submitted.
- Submission of the abstract constitutes the consent of all authors to publication (e.g. Conference website, programs, other promotions, etc.)
- The Abstract Submitter warrants and represents that no part of the information and content that they provide (Hereafter: the “Content“) to IPVS 2025 Conference, International Papillomavirus Society, and Kenes Group (Hereafter: the “Organizers“), nor the publication of any such Content by the Organizers, on the internet or otherwise infringes any third party rights, including but not limited to privacy rights and/or intellectual property rights.
- The Abstract Submitter grants the Organizers a copyright license to reproduce, publish, translate, distribute, and display the text of the Content on a royalty-free, perpetual, irrevocable nonexclusive basis.
- I herewith confirm that the contact details saved in this system are those of the presenting author, who will be notified about the status of the abstract. The presenting author is responsible for informing the other authors about the status of the abstract. The submitting author may request to be copied on the abstract correspondence.
- I understand that the presenting author must be a registered participant.
- The Organizers reserve the right to remove from publication and/or presentation an abstract that does not comply with the above.
- I understand that I must select a specific Topic and Sub-Topic for my abstract allocation. Although the Committee will work hard to honor this selection, this cannot be guaranteed. The Committee reserves the right to change the Topic or Sub-Topic under which the abstract was originally submitted.
Dear Colleagues and Friends,
On behalf of the Board of the International Papillomavirus Society (IPVS) and the Local Organizing Committee, we are delighted to invite you to participate in the 37th Annual Conference of the International Papillomavirus Society (IPVS2025), which will be held in Bangkok, Thailand, from October 23-26, 2025.
The theme of IPVS 2025 in Bangkok is “Research toward the Global Elimination of HPV-Related Diseases and Cancers.” This conference will serve as a key platform for presenting groundbreaking international research on HPV. Attendees will have the opportunity to participate in workshops led by prominent experts, covering the latest advancements in basic, public health, and clinical sciences. Additionally, a dedicated track for early-career scientists will offer young researchers a valuable opportunity to network and present their work.
Set in the vibrant city of Bangkok, known for its rich traditions and modern innovations, this year’s conference will bring together the global HPV community to collaborate on strategies to eliminate the burden of HPV-related diseases. Building on the Thai successes in managing and curbing the HIV epidemic, IPVS 2025 will prominently feature sessions highlighting the intersection of HPV and HIV infections and related diseases. Your participation and contributions are crucial in advancing our shared mission. As the global authority on papillomaviruses, we take great pride in disseminating the latest research and clinical trial results through a rigorous scientific review process. By covering a wide range of HPV associated diseases and ensuring that fundamental scientific research is integrated with clinical applications and public health policies, this comprehensive approach will cover the full spectrum of impactful research and intervention strategies.
We invite you to Bangkok in October 2025, where your invaluable expertise and dedication will help shape the future of HPV research, development of new efficacious interventions, for both prevention and treatment of diseases caused by HPV. We look forward to seeing you there!
Yours Sincerely,
Professor Anna R. Giuliano, PhD
IPVS President
IPVS 2025 Chair
注册费：
REGISTRATION FEES (Rates are in USD$)
Fees apply to payments received prior to the indicated deadlines (midnight CEST)
| Category |
Early Fee
Until July 30, 2025 |
Regular Fee
From July 31
To September 30, 2025 |
Late Fee
From October 1, 2025 |
| High-Income Countries** |
| IPVS Member* |
$999 |
$1,099 |
$1,199 |
| Discounted Package - IPVS Membership & Conference Registration |
$1,104 |
$1,204 |
$1,304 |
| Non-Member |
$1,179 |
$1,279 |
$1,379 |
| Upper-Middle Income Countries** |
| IPVS Member* |
$639 |
$739 |
$839 |
| Discounted Package - IPVS Membership & Conference Registration |
$669 |
$769 |
$869 |
| Non-Member |
$729 |
$829 |
$929 |
| Low & Lower-Middle Income countries** |
| IPVS Member* |
$349 |
$449 |
$549 |
| Discounted Package - IPVS Membership & Conference Registration |
$339 |
$439 |
$539 |
| Non-Member |
$389 |
$489 |
$589 |
| Early Career Researcher***** & Allied Health Professional***** |
| IPVS Member* |
$359 |
$459 |
$559 |
| Discounted Package - IPVS Membership & Conference Registration |
$389 |
$489 |
$589 |
| Non-Member |
$449 |
$549 |
$649 |
| Students**** |
| IPVS Member* |
$309 |
$409 |
$509 |
| Discounted Package - IPVS Membership & Conference Registration |
$314 |
$414 |
$514 |
| Non-Member |
$359 |
$459 |
$559 |
| Emeritus***** |
| IPVS Member* |
$639 |
$739 |
$839 |
| Discounted Package - IPVS Membership & Conference Registration |
$644 |
$744 |
$844 |
| Non-Member |
$699 |
$799 |
$899 |
| Joint Mentor & Student Special Rate (for two) |
| High-Income Countries (Active IPVS Members Only ****) |
$1,279 |
$1,379 |
$1,479 |
| Upper-Middle Income Countries (Active IPVS Members Only ****) |
$899 |
$999 |
$1,099 |
| Low & Lower-Middle Income Countries**(Active IPVS Members Only ****) |
$619 |
$719 |
$819 |
* Available for current IPVS members: individuals who have already joined IPVS or renewed their membership for 2025 (with valid membership up to 31st December 2025).
** Countries classification is defined according to the World Bank Country Classification. Click here for more information on the Country Classification data according to the World Bank website.
*** Online registration must be accompanied by an official letter confirming your status. The document is to be uploaded during the online registration process.
Student – Any student who is currently enrolled as an undergraduate or graduate student and has an interest in the field of papillomaviruses and papillomavirus-related diseases (requires a certificate as proof of their current student status).
Emeritus – Researcher and healthcare professionals who have retired or ceased to work full-time but wish to maintain an interest in the papillomavirus field.
****Definition of ECR and AHP:
Early Career Researcher – Researcher who has completed their final degree within the last 10 years.
Allied Health Professional – Nurse, social worker, nutritionist, psychologist, art therapist, physician assistant, who participates in research or care and treatment of patients with HPV.
***** IPVS Members who are mentoring pre-doctoral or post-doctoral trainees (who are also IPVS Members), can benefit from the combined mentor-trainee special rate for the 2 registrations. The details of both the mentor and the trainee should be provided in one registration.
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
